A new deep learning model using histopathology images identifies recurrence risk in stage II colorectal cancer more effectively than standard clinical predictors.
Key Details
- 1Researchers developed a deep learning model (SurvFinder) trained on whole slide histopathology images from stage II colorectal cancer patients.
- 2The study retrospectively analyzed multi-center data from patients in China and the United States.
- 3The AI model identified features associated with risk of recurrence at a higher success rate than traditional clinical prognostic tools.
- 4Study details and results are published in PLOS Medicine, open access.
Why It Matters
Digital pathology AI models can enhance prognostic accuracy and help personalize treatment plans for cancer patients. Outperforming current clinical tools could enable better risk stratification and improved outcomes in stage II colorectal cancer.
Source
EurekAlert
Related News
•EurekAlert
AI Framework Accelerates Aortic Aneurysm Risk Prediction from Imaging
Researchers developed BioPINN-LM, combining physics-informed neural networks and multimodal large language models to deliver fast, interpretable risk assessments for ascending thoracic aortic aneurysms.
•EurekAlert
Study Finds Patient Voices Missing in Generative AI Design for Oncology
A Flinders University-led review found patients and carers are rarely involved in shaping generative AI tools used in oncology.
•EurekAlert
Scripps Researchers Develop AI Foundation Model for ECG-Based Heart Disease Prediction
A new AI foundation model, ECG-CLIP, improves detection and prediction of multiple heart diseases using large-scale ECG and clinician note data.